- 1. Ibritumomab Tiuxetan
- [An immunoconjugate of monoclonal antibody ibritumomab conjugated with the linker-chelator tiuxetan. Ibritumomab is a murine IgG1 kappa monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes. This linker-chelator provides a high affinity, conformation restricted chelation site for Indium-111 or Yttrium-90 to be used in relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma, including patients with rituximab refractory follicular non-Hodgkin's lymphoma. ( NCI )] (UMLS (NCI) C0877880) IBRITUMOMAB TIUXETAN PREPARATION;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =[AN600] ANTINEOPLASTIC RADIOPHARMACEUTICALS;
Unclassified Ingredients =IBRITUMOMAB TIUXETAN 1.6 MG/ML;
| |
home
